| Literature DB >> 30338140 |
Brad A Hartl1, Htet S W Ma1, Shamira Sridharan1, Katherine S Hansen2, Michael S Kent2, Fredric Gorin3, Ruben C Fragoso4, Laura Marcu1.
Abstract
Current clinical imaging modalities do not reliably identify brain tissue regions with necrosis following radiotherapy. This creates challenges for stereotaxic biopsies and surgical-decision making. Time-resolved fluorescence spectroscopy (TRFS) provides a means to rapidly identify necrotic tissue by its distinct autofluorescence signature resulting from tissue breakdown and altered metabolic profiles in regions with radiation damage. Studies conducted in a live animal model of radiation necrosis demonstrated that necrotic tissue is characterized by respective increases of 27% and 108% in average lifetime and redox ratio, when compared with healthy tissue. Moreover, radiation-damaged tissue not visible by MRI but confirmed by histopathology, was detected by TRFS. Current results demonstrate the ability of TRFS to identify radiation-damaged brain tissue in real-time and indicates its potential to assist with surgical guidance and MRI-guided biopsy procedures.Entities:
Keywords: (170.3650) Lifetime-based sensing; (170.4580) Optical diagnostics for medicine; (170.6280) Spectroscopy, fluorescence and luminescence; (300.2530) Fluorescence, laser-induced
Year: 2018 PMID: 30338140 PMCID: PMC6191615 DOI: 10.1364/BOE.9.003559
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732